Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
SERVPRO Launches New Ready Plan™ App to Help Businesses Reduce Downtime After Disasters
-
ProQR to Host Virtual Investor and Analyst Event Highlighting Pipeline on April 8, 2026
-
Major Gift to Empire Club Foundation Launches Hal Jackman Future Nation Builder Awards to Support Canada’s Emerging Student Leaders
-
Recursion Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer
-
Identity and Biometric Authentication Cybersecurity Provider BIO-key to Host Year-End Investor Call Tuesday, March 31st at 10am ET
-
Pharma Equity Group A/S - Annual Report 2025
-
Volatus Aerospace Expands Global Training Network Through Strategic Partnership with University of Technology, Jamaica
-
Daniel Craig launches new range for DENZA ahead of global expansion
-
Urban-Gro Positioned to Capture Growth as T20 Cricket Franchise Valuations Exceed $1.6 Billion and Global Media Expansion Accelerates
-
Fixing of coupon rates - Nykredit Realkredit A/S
-
Clearlight® Expands Its Integrated Wellness Universe with the Debut of The Clearlight® Plunge
-
Canine Companions Experts Share How Puppies Become Life-Changing Service Dogs on YourUpdateTV: National Puppy Day: Meet the Next Generation of Service Dogs Live on Puppy Cam
-
Annual report for 2025
-
PROPOSED AMENDMENT TO THE PRINCIPAL AMOUNT OF THE AFFECTED SECURITIES ADJOURNMENT OF MEETING OF THE ETP SECURITYHOLDERS
-
Artelo Biosciences Expansion into $16.3B Glaucoma Market, Via Fully Funded Study, Highlights Multi-Platform Pipeline Strength
-
Aecon joint venture finalizes contract for the Howard A. Hanson Dam Facility project in Washington State
-
Brixton Metals Drills 82,334 g/t Silver (2,647 Ounces Per Tonne Silver) Over 0.5m within 11.35m of 4,560 g/t Silver at its Langis Project
-
Fredonia Mining Inc. Engages ICP Securities Inc. for Automated Market Making Services and Enters Into Investor Relations and Capital Markets Advisory Agreement
-
Marvel Biosciences Selects Novotech as CRO for Its Phase I Clinical Trial of MB-204
-
Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease
-
DelphX Announces Grant of Stock Options
-
Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer
-
Base Carbon Announces Fourth Issuance of Carbon Credits From Rwanda Cookstoves Project
-
Creative Realities Appoints Jackie Walker as CXO to Lead Experience Strategy and Next Generation SaaS Platform Vision
-
Rekor Systems Appoints Marc Segal as Director of Rekor Command® to Drive Expansion in Key Growth Markets
-
EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue
-
Bessor Announces Termination of Jagrite Graphite Project
-
Transfer of Huhtamäki Oyj's own treasury shares
-
Cipher Digital Announces Business Updates
-
HBT Financial, Inc. Announces Addition to Board of Directors
-
Bunzl Sets Global First: In-house CIMS‑GB Verification Experts
-
Lithium Ionic Secures Offtake Agreements with Leading Integrated Lithium Producers, Including One of the World’s Largest Lithium Hydroxide Producers, for Bandeira Project Production
-
Lightbridge to Serve on Industry Advisory Board of $6 Million DOE-Funded Project with Penn State
-
Condominiums: Still the Most Affordable Option Despite Rising Costs
-
Picard Medical Reports Full Year 2025 Financial Results
-
Dr. Bob Akmens & BASports.com Capture 7th Las Vegas MLB Exhibition Season Title in 9 Years
-
JPMorgan Announces Cash Distributions for the JPMorgan ETFs
-
NetraMark Announces Strategic Oncology Research Collaboration with Fondazione per la Medicina Personalizzata to Analyze Landmark ROME Trial Dataset
-
CMG Announces the Acquisition of Rose Subsurface Assessment
-
Westhaven Engages San Diego Torrey Hills Capital for Investor Relations
-
Algernon Health Announces NOVASCAN NEUROIMAGING CLINICS™ as the New Brand Name for its U.S. Brain PET Scanning Centers
-
Koryx Copper Announces Updated Mineral Resource Estimate for the Haib Copper Project, Southern Namibia
-
Garrett Motion to hold Technology and Investor Day on Wednesday May 20, 2026 in New York City
-
NexGold Initiates 30,000-Metre Infill Drill Program at the Goldboro Gold Project in Nova Scotia
-
Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceuticals US, Inc.
-
Maze Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights
-
Maze Therapeutics Announces Positive Topline Data from Phase 2 HORIZON Trial of MZE829 Demonstrating the First Clinical Proof-of-Concept in Patients with Broad APOL1-Mediated Kidney Disease
-
Dr. Bob Akmens & BASports.com Capture 7th Las Vegas MLB Exhibition Season Title in 9 Years
-
Endogenex Closes $50 Million Series C Extension to Fund Pivotal Clinical Study and Path to FDA Approval
-
C4 Therapeutics Announces First Patient Dosed in Phase 1b Trial of Cemsidomide in Combination with Elranatamab (ELREXFIO®) for Relapsed/Refractory Multiple Myeloma
